SyneuRx Initiates Clinical Trial SNB01 Pentarlandir® For Covid-19
SyneuRx Initiates Clinical Trial SNB01 Pentarlandir® For Covid-19 Press Release Apr 27, 2021 Taipei, Taiwan, April 27, 2021 -- SyneuRx International (Taiwan) Corp. (TWSE:6575), announced today that a kick-off meeting…